Here are the latest stories being discussed in biopharma today:

Sanofi Closing Dutch NK Cell Therapy Biotech

French pharmaceutical company Sanofi is closing Kiadis, a Dutch natural killer (NK) cell company it bought for $357 million in 2020. A recent update to a clinical trial for SAR445419, an off-the-shelf NK cell therapy being developed for relapsed/refractory acute myeloid leukemia, revealed the change.

Novartis to Downsize Development Team

Swiss pharmaceutical giant Novartis intends to downsize its global development team by up to 680 positions, with the most significant impact expected in Switzerland where up to 440 roles may be eliminated, while up to 240 roles may be affected in the U.S.

AstraZeneca Testing ‘Radiosensitizer’ for Brain Cancer

Researchers are investigating whether experimental drug AZD1390 developed by AstraZeneca, in conjunction with radiation therapy, could improve radiation’s efficacy in treating glioblastoma, a particularly aggressive brain cancer.

Virginia Governor Vetoes Drug Price Reduction Bill

Virginia Governor Glenn Youngkin recently vetoed legislation proposing an advisory board to help manage the state’s prescription drug costs. This marks a setback in efforts to implement price ceilings on certain high-cost treatments.

Indian Pharma Company Gets FDA Warning

Indian pharmaceutical firm Kilitch Healthcare has received a warning letter from the FDA noting infractions including employees working barefoot in clean rooms and fabricated test results. These issues were discovered after a recall of eye drop products.

Lady Gaga Stars in New Pfizer Ad

Pop star Lady Gaga is featured in a new subdued advertising campaign for Pfizer’s migraine medication Nurtec ODT. Unlike the previous concert-themed ad, the new commercial shows Gaga photographing diverse groups of actual Nurtec ODT patients.